155 related articles for article (PubMed ID: 16242914)
1. BAFF is elevated in serum of patients with Wegener's granulomatosis.
Krumbholz M; Specks U; Wick M; Kalled SL; Jenne D; Meinl E
J Autoimmun; 2005 Dec; 25(4):298-302. PubMed ID: 16242914
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.
Toubi E; Gordon S; Kessel A; Rosner I; Rozenbaum M; Shoenfeld Y; Zuckerman E
J Autoimmun; 2006 Sep; 27(2):134-9. PubMed ID: 17029886
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
[TBL] [Abstract][Full Text] [Related]
5. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease.
Fabris M; Visentini D; De Re V; Picierno A; Maieron R; Cannizzaro R; Villalta D; Curcio F; De Vita S; Tonutti E
Scand J Gastroenterol; 2007 Dec; 42(12):1434-9. PubMed ID: 17852877
[TBL] [Abstract][Full Text] [Related]
6. Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia.
Molica S; Digiesi G; Mauro F; Mirabelli R; Cutrona G; Vitelli G; Morabito F; Iuliano F; Foà R; Ferrarini M
Leuk Res; 2009 Jan; 33(1):162-5. PubMed ID: 18556064
[TBL] [Abstract][Full Text] [Related]
7. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
8. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
9. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis.
Bosello S; Youinou P; Daridon C; Tolusso B; Bendaoud B; Pietrapertosa D; Morelli A; Ferraccioli G
J Rheumatol; 2008 Jul; 35(7):1256-64. PubMed ID: 18528969
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum BAFF levels in patients with autoimmune hepatitis.
Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
[TBL] [Abstract][Full Text] [Related]
13. Serum BAFF expression in patients with myasthenia gravis.
Kim JY; Yang Y; Moon JS; Lee EY; So SH; Lee HS; Park KD; Choi YC
J Neuroimmunol; 2008 Aug; 199(1-2):151-4. PubMed ID: 18586330
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
15. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.
Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K
Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352
[TBL] [Abstract][Full Text] [Related]
16. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
17. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Hoefgen ER; Swan JA; Colliver JA
Cytokine; 2008 Oct; 44(1):26-32. PubMed ID: 18675552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
